- COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases, and other serious comorbid conditions
Author: Tsai et al.
Date: 09-Apr-21
Journal: medRxiv
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
Author: Waissengrin et al.
Date: 01-Apr-21
Journal: The Lancet Oncology
- SARS-CoV-2 vaccination for patients with solid cancer: Review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER)
Author: Tougeron et al.
Date: 01-Apr-21
Journal: European Journal of Cancer
- Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
Author: Mansi et al.
Date: 26-Mar-21
Journal: European Journal of Cancer
- Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar
Author: Kelkar et al.
Date: 25-Mar-21
Journal: Healthcare
- COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
Author: Silvestris et al.
Date: 17-Mar-21
Journal: ESMO Open
- Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
Author: Monin-Aldama et al.
Date: 17-Mar-21
Journal: medRxiv
- COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Author: Desai et al.
Date: 15-Mar-21
Journal: Nature Reviews Clinical Oncology
- COVID-19 vaccine hesitancy among blood cancer patients
Author: Conti et al.
Date: 08-Mar-21
Journal: Leukemia & Lymphoma Society
- Delaying second vaccine dose leaves cancer patients vulnerable to virus
Author: Irshad et al.
Date: 11-Mar-21
Journal: n/a
- COVID-19 vaccine prioritisation for medical students: The forgotten cohort?
Author: Lim et al.
Date: 02-Mar-21
Journal: Clincal Oncology
- Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients
Author: Loupakis et al.
Date: 26-Feb-21
Journal: Critical Reviews in Oncology/Hematology
- COVID-19 vaccines for patients with cancer: Benefits likely outweigh risks
Author: Hwang et al.
Date: 26-Feb-21
Journal: Journal of Hematology & Oncology
- Current perspectives: SARS-CoV-2 vaccines for cancer patients: A call to action
Author: Corti et al.
Date: 24-Feb-21
Journal: European Journal of Cancer
- Lymphadenopathy in COVID-19 vaccine recipients: Diagnostic dilemma in oncology patients
Author: Özütemiz et al.
Date: 24-Feb-21
Journal: Radiology
- SARS-CoV-2 vaccines in patients with multiple myeloma
Author: Gavriatopoulou et al
Date: 17-Feb-21
Journal: Hemasphere
- COVID-19 vaccination: The VOICE for patients with cancer
Author: van der Veldt et al.
Date: 15-Feb-21
Journal: Nature Medicine
- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
Author: Garassino et al.
Date: 11-Feb-21
Journal: Annals of Oncology
- SARS-CoV-2 vaccination and phase 1 cancer clinical trials
Author: Yap et al.
Date: 08-Feb-21
Journal: The Lancet Oncology
- COVID vaccination in cancer patients: What vaccination priority strategies should there be?
Author: Silvestris et al.
Date: 04-Feb-21
Journal: Frontiers in Oncology
- Challenges and opportunities for COVID-19 vaccines in patients with cancer
Author: Kuderer et al.
Date: 03-Feb-21
Journal: Cancer Investigation
- Professionally responsible COVID-19 vaccination counseling of obstetric/gynecologic patients: Counseling patients about COVID-19 vaccination
Author: Chervenak et al.
Date: 01-Feb-21
Journal: American Journal of Obstetrics and Gynecology
- COVID-19, the future vaccine and what it means for cancer patients on immunotherapy
Author: El-Shakankery et al.
Date: 01-Feb-21
Journal: Frontiers in Oncology
- Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
Author: Barriere et al.
Date: 29-Jan-21
Journal: Annals of Oncology
- COVID-19 vaccines: Preparing for vaccination in the context of clinical oncology care
Author: Carr et al.
Date: 22-Jan-21
Journal: Clinical Journal of Oncology Nursing
- COVID-19 vaccine race: Watch your step for cancer patients
Author: Fanciullino et al.
Date: 07-Dec-20
Journal: British Journal of Cancer
Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.
If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.
Freecall 1800 624 973
+61 2 9357 9400
Locked Bag 3, Strawberry Hills
NSW 2012